Literature DB >> 11146757

Association of schizophrenia with low maternal body mass index, small size at birth, and thinness during childhood.

K Wahlbeck1, T Forsén, C Osmond, D J Barker, J G Eriksson.   

Abstract

BACKGROUND: Nutritional factors in early life may contribute to the neurodevelopmental deficit in schizophrenia. This study explores the influence of maternal body size, size at birth, and childhood growth on future risk for schizophrenia. SUBJECTS AND METHODS: This population-based cohort study comprised births at Helsinki University Central Hospital in Helsinki, Finland, from 1924 to 1933. Prospective data from birth and school health records of 7086 individuals were collected and linked to the Finnish Hospital Discharge Register.
RESULTS: Schizophrenia or schizoaffective disorder had been diagnosed in 114 individuals. A lower late-pregnancy maternal body mass index (BMI) increased the risk (odds ratio [OR], 1.09 per kilogram/meter(2); 95% confidence interval [CI], 1.02-1.17) for schizophrenia among the offspring. The risk of schizophrenia increased with low birth weight (OR, 1.48 per kilogram; 95% CI, 1.03-2.13), shortness at birth (OR, 1.12 per centimeter; 95% CI, 1.03-1.22), and low placental weight (OR, 1.22 per 100 g; 95% CI, 1.04-1.43). Schizophrenia cases were thinner than comparison subjects from 7 to 15 years of age. In a joint model comprising late-pregnancy maternal BMI, body size at birth, and childhood BMI, childhood BMI was an independent predictor of schizophrenia, whereas other factors exhibited attenuated effects.
CONCLUSION: Indicators of intrauterine and childhood undernutrition are associated with an increased lifetime risk of schizophrenia.

Entities:  

Mesh:

Year:  2001        PMID: 11146757     DOI: 10.1001/archpsyc.58.1.48

Source DB:  PubMed          Journal:  Arch Gen Psychiatry        ISSN: 0003-990X


  50 in total

Review 1.  Recent advances in the genetics of schizophrenia.

Authors:  D M Waterwort; A S Bassett; L M Brzustowicz
Journal:  Cell Mol Life Sci       Date:  2002-02       Impact factor: 9.261

Review 2.  Molecular aspects of glutamate dysregulation: implications for schizophrenia and its treatment.

Authors:  Christine Konradi; Stephan Heckers
Journal:  Pharmacol Ther       Date:  2003-02       Impact factor: 12.310

3.  Incidence of hospitalised schizophrenia in Finland since 1980: decreasing and increasing again.

Authors:  Raimo K R Salokangas; Mika Helminen; Anna-Maija Koivisto; Helena Rantanen; Hannu Oja; Sami Pirkola; Kristian Wahlbeck; Matti Joukamaa
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2010-03-20       Impact factor: 4.328

Review 4.  The environment and susceptibility to schizophrenia.

Authors:  Alan S Brown
Journal:  Prog Neurobiol       Date:  2010-10-16       Impact factor: 11.685

Review 5.  The developmental origins of adult disease.

Authors:  Peter D Gluckman; Mark A Hanson; Catherine Pinal
Journal:  Matern Child Nutr       Date:  2005-07       Impact factor: 3.092

6.  Parental history of type 2 diabetes in patients with nonaffective psychosis.

Authors:  Emilio Fernandez-Egea; Brian Miller; Miguel Bernardo; Thomas Donner; Brian Kirkpatrick
Journal:  Schizophr Res       Date:  2007-11-26       Impact factor: 4.939

7.  Schizophrenia as a systemic disease.

Authors:  Brian Kirkpatrick
Journal:  Schizophr Bull       Date:  2009-02-04       Impact factor: 9.306

8.  A classification of sociomedical health indicators: perspectives for health administrators and health planners.

Authors:  A E Siegmann
Journal:  Int J Health Serv       Date:  1976       Impact factor: 1.663

9.  Childhood determinants of adult psychiatric disorder.

Authors:  Tom Fryers; Traolach Brugha
Journal:  Clin Pract Epidemiol Ment Health       Date:  2013-02-22

Review 10.  Is schizophrenia a syndrome of accelerated aging?

Authors:  Brian Kirkpatrick; Erick Messias; Philip D Harvey; Emilio Fernandez-Egea; Christopher R Bowie
Journal:  Schizophr Bull       Date:  2007-12-21       Impact factor: 9.306

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.